Results 241 to 250 of about 600,930 (299)

Isolation and usage of exosomes in central nervous system diseases. [PDF]

open access: yesCNS Neurosci Ther
Wang W   +6 more
europepmc   +1 more source

Ergothioneine and central nervous system diseases

Neurochemical Research, 2022
Ergothioneine (ERGO) is a thiol contained in the food that exhibits an excellent antioxidant effect similar to that of glutathione. Although mammals lack a biosynthetic pathway for ERGO, the carnitine/organic cation transporter OCTN1/SLC22A4, which transports ERGO in vivo, is expressed throughout the body, and ERGO is distributed to various organs ...
Noritaka Nakamichi   +2 more
openaire   +2 more sources

Batokine in Central Nervous System Diseases

Molecular Neurobiology, 2023
Brown adipose tissue (BAT) is a special type of fat tissue in mammals and is also a key endocrine organ in the human body. Batokine, the endocrine effector of BAT, plays a neuroprotective role and improves the prognosis by exerting anti-apoptotic and anti-inflammatory effects, as well as by improving vascular endothelial function and other mechanisms ...
Ming Shen   +3 more
openaire   +2 more sources

Central nervous system Lyme disease

Seminars in Pediatric Infectious Diseases, 2003
Lyme disease is a disease caused by the spirochete, Borrelia burgdorferi. It is transmitted to humans via a bite from an infected tick. It has several classic stages or categories of illness, including early localized disease, early disseminated disease, and late disease.
Sharon A, Nachman, Lucy, Pontrelli
openaire   +2 more sources

Amyloid in central nervous system disease

Clinical Neurology and Neurosurgery, 1990
A review is presented of diseases of the central nervous system associated with amyloid deposition. The name amyloid is given to substances with particular physical characteristics which are independent of the chemical constitution of the proteins in the substance.
J, Haan, R A, Roos
openaire   +2 more sources

Home - About - Disclaimer - Privacy